Neogen Corporation reported $884M of revenue over the trailing twelve months, −0.33% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $884M (to Q1 2027). Net income: −$56M, trailing twelve months to Q1 2027. Free cash flow: $50M, trailing twelve months to Q1 2027. Operating margin: −0.85%, trailing twelve months to Q1 2027.

NEOGNeogen Corporation

Healthcare

$12.19+106% 1Y

$12.19

$5.4152 weeks$13.99

NEOG as reported

Neogen Corporation reported $884M of revenue over the trailing twelve months, −0.33% on the year before. 11 reported series are charted on this page, each one as filed.

$884M

Revenue, trailing twelve months · to Q1 2027 · −0.33% against the twelve months before

Net income: −$56M
Net income · −95% year on year · trailing twelve months to Q1 2027
Free cash flow: $50M
Free cash flow · −1631% year on year · trailing twelve months to Q1 2027
Operating margin: −0.85%
Operating margin · trailing twelve months to Q1 2027

Details›

Every series Ryufin has for NEOG, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$884M	−0.33%	Q1 2027
Net income	−$56M	−95%	Q1 2027
EPS	−$0.26	−95%	Q1 2027
Gross margin	47%	n/a	Q1 2027
Operating margin	−0.85%	n/a	Q1 2027
Net margin	−6.4%	n/a	Q1 2027
ROE	−15%	n/a	Q1 2027
ROA	−9.5%	n/a	Q1 2027
ROIC	−7.2%	n/a	Q1 2027
Free cash flow	$50M	−1631%	Q1 2027
P/E	68.4	n/a	Q1 2023 · 16 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.